Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.
Singh
V
V
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sud
K
K
Mittal
B R
BR
Kohli
H S
HS
Gupta
K L
KL
Sakhuja
V
V
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004906:Erythrocyte Count; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D008297:Male; D011086:Polycythemia / Q000188:drug therapy / Q000453:epidemiology*; D011183:Postoperative Complications / Q000188:drug therapy / Q000453:epidemiology*; D011446:Prospective Studies; D012078:Renal Artery Obstruction / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D012907:Smoking
D000806:Angiotensin-Converting Enzyme Inhibitors; D006454:Hemoglobins; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine